Marrone Bio Innovations
(NASDAQ) MBII
Marrone Bio Innovations Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$44.37M
Net Income (TTM)
$20.89M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MBII News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Marrone Bio Innovations
Industry
Chemicals
Sector
MaterialsEmployees
153
CEO
Kevin R. Helash
Website
www.marronebio.comHeadquarters
Davis, CA 27617, US
MBII Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
-34%
Net Income Margin
-37%
Return on Equity
-54%
Return on Capital
-36%
Return on Assets
-19%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$27.25M
Operating Income
$14.94M
EBITDA
$10.37M
Operating Cash Flow
$9.96M
Capital Expenditure
$1.09M
Free Cash Flow
$11.05M
Cash & ST Invst.
$19.62M
Total Debt
$37.49M
Marrone Bio Innovations Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$11.10M
+0.5%
Gross Profit
$6.21M
-10.9%
Gross Margin
55.93%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
153
N/A
Net Income
$7.60M
-132.9%
EBITDA
$5.86M
-237.3%
Quarterly Fundamentals
Net Cash
$26.10M
-63.8%
Accounts Receivable
$12.11M
-10.5%
Inventory
$10.12M
+57.8%
Long Term Debt
$9.74M
-54.9%
Short Term Debt
$25.71M
+94.1%
Return on Assets
-19.02%
N/A
Return on Invested Capital
-35.68%
N/A
Free Cash Flow
$8.59M
-67.3%
Operating Cash Flow
$8.40M
-67.4%